Vanda Pharmaceuticals announces the publication of "Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis" in NEJM Evidence

/C O R R E C T I O N -- Elanco Animal Health/

Timberland Bancorp Reports Second Fiscal Quarter Net Income of $7.1 Million

CPKC increases dividend by 17.5 percent

Waldencast announces conclusion of SEC investigation

Nektar to Announce Financial Results for the First Quarter on Thursday, May 7, 2026, After Close of U.S.-Based Financial Markets

F5 to Host Analyst and Investor Meeting on May 28, 2026

HII’s Ingalls Shipbuilding is Awarded Frigate Lead Yard Support Contract

Sunrun Prices $584 million Securitization of Residential Solar and Storage Assets

Madison Air Schedules First Quarter 2026 Earnings Conference Call and Webcast

Ultra Clean Announces Retirement of the Chief Financial Officer Sheri Savage

GridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing

Rush Enterprises, Inc. Reports First Quarter 2026 Results, Announces $0.19 Per Share Dividend

EVgo to Report First Quarter 2026 Results on May 5

Sound Financial Bancorp, Inc. Q1 2026 Results

ENEL CHILE ANNOUNCES THE FILING OF THE 2025 ANNUAL REPORT ON FORM 20-F

Select Medical Holdings Corporation Announces Expiration of Hart-Scott-Rodino Waiting Period

Leading CDMO Selects Kneat to Power Digital Validation Transformation

Ashland reports second quarter fiscal 2026 results and updates full-year outlook

Meryllion Announces New Non-Brokered LIFE Financing